EP

Eversept Partners Portfolio holdings

AUM $1.78B
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+97.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.78B
AUM Growth
+$478M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
122
New
Increased
Reduced
Closed

Top Buys

1
+$27.7M
2
+$26.1M
3
+$25.2M
4
EXAS icon
Exact Sciences
EXAS
+$19.4M
5
DHR icon
Danaher
DHR
+$19.1M

Top Sells

1
+$39.4M
2
+$38.6M
3
+$31.4M
4
RVTY icon
Revvity
RVTY
+$22.2M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$17.3M

Sector Composition

1 Healthcare 99.91%
2 Financials 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVP icon
101
Retractable Technologies
RVP
$21.3M
$449K 0.03%
580,919
+217,604
SSII
102
SS Innovations International
SSII
$859M
$428K 0.02%
+75,358
CBLL
103
CeriBell Inc
CBLL
$694M
$375K 0.02%
17,094
DYN icon
104
Dyne Therapeutics
DYN
$3.26B
– –
-10,000
ETNB
105
DELISTED
89bio
ETNB
– –
-392,441
GOSS icon
106
Gossamer Bio
GOSS
$117M
– –
-925,233
KRRO icon
107
Korro Bio
KRRO
$108M
– –
-20,856
KURA icon
108
Kura Oncology
KURA
$806M
– –
-263,628
MIRM icon
109
Mirum Pharmaceuticals
MIRM
$5.49B
– –
-49,314
MRUS
110
DELISTED
Merus
MRUS
– –
-48,054
NKTR icon
111
Nektar Therapeutics
NKTR
$2.02B
– –
-49,890
NVO icon
112
Novo Nordisk
NVO
$172B
– –
-217,708
QQQ icon
113
Invesco QQQ Trust
QQQ
$393B
– –
0
REPL icon
114
Replimune Group
REPL
$680M
– –
-59,992
RGEN icon
115
Repligen
RGEN
$6.86B
– –
-105,087
RNAM
116
DELISTED
Avidity Biosciences
RNAM
– –
-302,911
SPY icon
117
State Street SPDR S&P 500 ETF Trust
SPY
$678B
– –
0
TLT icon
118
iShares 20+ Year Treasury Bond ETF
TLT
$44.7B
– –
0
XBI icon
119
State Street SPDR S&P Biotech ETF
XBI
$8.09B
– –
0
ZIMV
120
DELISTED
ZimVie
ZIMV
– –
-2,079,380
ATYR
121
aTyr Pharma
ATYR
$91.7M
– –
0
PVLA
122
Palvella Therapeutics
PVLA
$1.99B
– –
-11,343
1 2 3 4
5